A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer. (Q44785268)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer. |
scientific article published in March 2004 |
Statements
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer (English)
M Mansutti
A Martoni
G Lelli
F Buzzi
G Robustelli Della Cuna
A Jirillo
E Terzoli
L Frevola
E Tarenzi
C Sguotti
N Azli
1 March 2004